Jeffrey Davis is a member at Bass, Berry & Sims who advises healthcare organizations on Medicare and Medicaid billing and reimbursement issues, with a special focus on the federal 340B drug pricing program.
Michael Hess is a member at Bass, Berry & Sims who leads the firm’s Specialty Pharmacy & Pharmaceuticals Practice Group.
Shannon Wiley is a member at Bass, Berry & Sims who focuses her practice on healthcare regulatory and transactional matters with a specific emphasis on specialty pharmacy, digital pharmacy and infusion providers.
In recent years, manufacturers have restricted access to 340B pricing for drugs dispensed through contract pharmacies. The federal government has advised manufacturers that such restrictions are unlawful, and manufactures have challenged government enforcement actions in federal court.